-
1
-
-
0023219060
-
Excitotoxicity and the NMDA receptor
-
Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurol Sci 1987;10:299-302.
-
(1987)
Trends Neurol Sci
, vol.10
, pp. 299-302
-
-
Rothman, S.M.1
Olney, J.W.2
-
2
-
-
0029131026
-
Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia
-
Meldrum BS. Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia. Ann N Y Acad Sci 1995;757:492-505.
-
(1995)
Ann N Y Acad Sci
, vol.757
, pp. 492-505
-
-
Meldrum, B.S.1
-
3
-
-
0023550787
-
Protection against hypoxic/ischaemic brain damage with excitatory amino acid antagonists
-
Meldrum BS, Evans MC, Swan JH, et al. Protection against hypoxic/ischaemic brain damage with excitatory amino acid antagonists. Med Biol 1987;65:153-7.
-
(1987)
Med Biol
, vol.65
, pp. 153-157
-
-
Meldrum, B.S.1
Evans, M.C.2
Swan, J.H.3
-
4
-
-
0025012027
-
The effect of NMDA receptor glycine site antagonista on hypoxia-induced neurodegeneration of rat cortical cell cultures
-
Priestley T, Horne AL, Mc Kernan RM, et al. The effect of NMDA receptor glycine site antagonista on hypoxia-induced neurodegeneration of rat cortical cell cultures. Brain Res 1990;531: 183-8.
-
(1990)
Brain Res
, vol.531
, pp. 183-188
-
-
Priestley, T.1
Horne, A.L.2
Mc Kernan, R.M.3
-
5
-
-
0023189044
-
The interaction between MK-801 and receptors for N-methyl-D-aspartate: Functional consequences
-
Woodruff GN, Foster AC, Gill R, et al. The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology 1987;26:903-9.
-
(1987)
Neuropharmacology
, vol.26
, pp. 903-909
-
-
Woodruff, G.N.1
Foster, A.C.2
Gill, R.3
-
6
-
-
0023738159
-
Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure
-
Goldman RS, Finkbeiner SM. Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. N Engl J Med 1988;319:1224-5.
-
(1988)
N Engl J Med
, vol.319
, pp. 1224-1225
-
-
Goldman, R.S.1
Finkbeiner, S.M.2
-
7
-
-
0022510777
-
Protection against experimental ischemic spinal cord injury
-
Robertson CS, Foltz R, Grossman RG, et al. Protection against experimental ischemic spinal cord injury. J Neurosurg 1986;64:633-42.
-
(1986)
J Neurosurg
, vol.64
, pp. 633-642
-
-
Robertson, C.S.1
Foltz, R.2
Grossman, R.G.3
-
8
-
-
0028130613
-
Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping
-
Simpson JI, Eide TR, Schiff GA, et al. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping. Anesthesiology 1994;81:1493-9.
-
(1994)
Anesthesiology
, vol.81
, pp. 1493-1499
-
-
Simpson, J.I.1
Eide, T.R.2
Schiff, G.A.3
-
9
-
-
0020585505
-
Synaptic activity mediates death of hypoxic neurons
-
Rothman SM. Synaptic activity mediates death of hypoxic neurons. Science 1983;220:536-7.
-
(1983)
Science
, vol.220
, pp. 536-537
-
-
Rothman, S.M.1
-
10
-
-
0023701305
-
Magnesium and cobalt, not nimodipine, potect neurons against anoxic damage in the rat hippocampal slice
-
Kass IS, Cottrell JE, Chambers G. Magnesium and cobalt, not nimodipine, potect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology 1988;69:710-5.
-
(1988)
Anesthesiology
, vol.69
, pp. 710-715
-
-
Kass, I.S.1
Cottrell, J.E.2
Chambers, G.3
-
11
-
-
0011811694
-
Application of quantitative measurements for assessing neurotoxicity
-
Finkbeiner SM, Stevens CF. Application of quantitative measurements for assessing neurotoxicity. Proc Natl Acad Sci U S A 1988;85:4071-1.
-
(1988)
Proc Natl Acad Sci U S A
, vol.85
, pp. 4071-4071
-
-
Finkbeiner, S.M.1
Stevens, C.F.2
-
12
-
-
0029004929
-
Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial
-
Duley L and eclampsia trial colloberative group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995;345:1455-63.
-
(1995)
Lancet
, vol.345
, pp. 1455-1463
-
-
Duley, L.1
-
13
-
-
0001173050
-
Spectrophotometric determination of magnesium withsodium-1-azo-2-hydroxy-3-(2.4-dimethylcarboxanilido)-naphtalene-1-(2- hydroxy-benzene-5 sulphonate)
-
Mann CR, Yoe JH. Spectrophotometric determination of magnesium withsodium-1-azo-2-hydroxy-3-(2.4-dimethylcarboxanilido)-naphtalene-1-(2- hydroxy-benzene-5 sulphonate). Anal Chem 1956;28: 202-5.
-
(1956)
Anal Chem
, vol.28
, pp. 202-205
-
-
Mann, C.R.1
Yoe, J.H.2
-
14
-
-
0022920857
-
Measurement of magnesium in serum and urine with a random access analyzer by use of modified xylidyl blue procedure
-
Radge D, Kohse P, Wisser H. Measurement of magnesium in serum and urine with a random access analyzer by use of modified xylidyl blue procedure. Clin Chim Acta 1986;159:197-203.
-
(1986)
Clin Chim Acta
, vol.159
, pp. 197-203
-
-
Radge, D.1
Kohse, P.2
Wisser, H.3
-
16
-
-
0023549341
-
Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report
-
Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987; 157:1435.
-
(1987)
Am J Obstet Gynecol
, vol.157
, pp. 1435
-
-
Thurnau, G.R.1
Kemp, D.B.2
Jarvis, A.3
-
17
-
-
0342590916
-
Cerebrospinal Fluid
-
Cottrell JE, Smith DS, eds. St. Louis: Moby Year Book
-
Artru AA. Cerebrospinal Fluid. In: Cottrell JE, Smith DS, eds. Anesthesia and Neurosurgery. St. Louis: Moby Year Book; 1994: 93-116.
-
(1994)
Anesthesia and Neurosurgery
, pp. 93-116
-
-
Artru, A.A.1
-
18
-
-
0013768618
-
Magnesium exchange between blood and cerebrospinal fluid
-
Oppelt WW, MacIntyre I, Rall DP. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963;205:959-62.
-
(1963)
Am J Physiol
, vol.205
, pp. 959-962
-
-
Oppelt, W.W.1
MacIntyre, I.2
Rall, D.P.3
-
19
-
-
0014402813
-
Blood-brain barrier: Evidence for active cation transport between blood and the extracellular fluid of the brain
-
Bito LZ. Blood-brain barrier: evidence for active cation transport between blood and the extracellular fluid of the brain. Science 1969;165:81-3.
-
(1969)
Science
, vol.165
, pp. 81-83
-
-
Bito, L.Z.1
-
20
-
-
0026683789
-
Peripheral magnesium sulfate enters the brain and increase the threshold for hippocampal seizures in rats
-
Hallak M, Berman RF, Irtenkauf SM, Evans MI, Cotton B. Peripheral magnesium sulfate enters the brain and increase the threshold for hippocampal seizures in rats. Am J Obstet Gynecol 1992;167: 1605-10.
-
(1992)
Am J Obstet Gynecol
, vol.167
, pp. 1605-1610
-
-
Hallak, M.1
Berman, R.F.2
Irtenkauf, S.M.3
Evans, M.I.4
Cotton, B.5
-
21
-
-
0027024995
-
Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: Neurological symptoms
-
Morris ME. Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magn Res 1992;5:303-13.
-
(1992)
Magn Res
, vol.5
, pp. 303-313
-
-
Morris, M.E.1
-
22
-
-
0026601171
-
Clinical use of magnesium infusions in anesthesia
-
James MFM. Clinical use of magnesium infusions in anesthesia. Anesth Analg 1992;74:129-36.
-
(1992)
Anesth Analg
, vol.74
, pp. 129-136
-
-
James, M.F.M.1
-
23
-
-
0030062683
-
Role of magnesium sulfate in postoperative analgesia
-
Tramèr MR, Schneider J, Marti RA, et al. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996;84:340-7.
-
(1996)
Anesthesiology
, vol.84
, pp. 340-347
-
-
Tramèr, M.R.1
Schneider, J.2
Marti, R.A.3
|